Safety Considerations and Provider Guidance Both peptides generally show favorable safety profiles in clinical contexts, but individual risk factors and medical histories influence suitability
With Semaglutide, no risk of major adverse cardiovascular events was reported
Patients receiving tirzepatide at the highest dose achieved mean weight reductions of 20-22% of body weight over 72 weeks, significantly outperforming single-pathway GLP-1 agents
But while these antioxidants are important for your health, there are two antioxidants that you may not know of
If you do have decreased kidney function and your doctor recommends methylcobalamin, you may need a much higher dose because its less stable, so be sure to ask them about whats best given your condition
Click here to view Product Info Sheet (Not on website) References: Richie JP, Nichenametla S, Neidig W, et al